Six months of hybrid closed-loop therapy improves diabetes-specific positive well-being, and reduces diabetes distress and fear of hypoglycemia: secondary analysis of a randomized controlled trial.
Halliday JA, Russell-Green S, Lam B, Trawley S, McAuley SA, Bach LA, Burt MG, Cohen ND, Colman PG, Davis EA, Holmes-Walker DJ, Jenkins AJ, Kaye J, Keech AC, Lee MH, McCallum RW, Paldus B, Stranks SN, Sundararajan V, Ward G, Jones TW, O'Neal D, Speight J, Hendrieckx C; Australian JDRF Closed-Loop Research Group Members.
Halliday JA, et al. Among authors: lee mh.
BMJ Open Diabetes Res Care. 2024 Dec 22;12(6):e004428. doi: 10.1136/bmjdrc-2024-004428.
BMJ Open Diabetes Res Care. 2024.
PMID: 39797667
Clinical Trial.